Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan's Health Ministry Approves 197 Generics For NHI Listing, Including 22 Generic Versions Of Pfizer's Xalatan Eye Drops

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Japan's Ministry of Health Labor and Welfare May 28 released for National Health Insurance coverage listing a total of 197 generic drugs, down sharply from the 318 items listed in May 2009; the decline seems to contradict the Japanese government's policy goal of raising the proportion of generics to 30 percent by the end of March 2013 from 17.6 percent in March 2009

Latest Headlines
See All
UsernamePublicRestriction

Register

SC075017

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel